["{\n\"step_by_step_thinking\": \"The question is asking for a condition where non-pulsatile dose of GnRH agonist is not used. Let's review the documents: Induction of puberty mentions long-term treatment with high-dose LHRH, but it doesn't specify if it's pulsatile or non-pulsatile. Gonadotropin-releasing hormone agonist-induced ovarian hyperstimulation talks about low-dose side effects in women and monkeys, but it doesn't mention a specific condition where non-pulsatile dose of GnRH agonist is used. Multiple follicular development in women with normal menstrual cycles treated with pulsatile gonadotrophin-releasing hormone mentions treatment with pulsatile GnRH for one to four cycles. GnRH antagonists suppress prolactin release in non-human primates discusses the effects of a GnRH antagonist on LH and Prl pulses, but it doesn't mention non-pulsatile dose of GnRH agonist use. Effect of administration of testosterone and gonadotrophin-releasing hormone (GnRH) antagonist on basal and GnRH-stimulated gonadotrophin secretion in orchidectomized monkeys talks about the effects of GnRH antagonist on gonadotrophin release, but it doesn't mention non-pulsatile dose of GnRH agonist use. Based on these documents, we can conclude that...\", \n\"answer_choice\": \"C\""]